cjc 1295 ipamorelin hot flush CJC-1295 + CJC-1295 / Ipamorelin Peptide Therapy:
Description
Patients who experience a relapse within six months after completing first-line platinum therapy are classified as platinum-resistant [94]
doi: 10.1046/j.1365-2249.2002.01825.x [DOI] [PMC free article] [PubMed] [Google Scholar] 67.Donath MY, Shoelson SE
miR-133a enhances the sensitivity of Hep-2 cells and vincristine-resistant Hep-2v cells to cisplatin by downregulating ATP7B expression
Interaction between cerebrovascular disease and Alzheimer pathology
